Cromolyn ophthalmic Pregnancy and Breastfeeding Warnings
Cromolyn ophthalmic is also known as: Crolom, Opticrom
Cromolyn ophthalmic Pregnancy Warnings
Cromolyn ophthalmic has been assigned to pregnancy category B by the FDA. Animal studies using doses up to 205 times the normal human dose have revealed no evidence of teratogenicity. Increased fetal resorption and decreased fetal weight occurred at maternotoxic parenteral doses. There are no controlled data in human pregnancy; however, data available suggest cromolyn use in human pregnancy is not associated with fetal toxicity or teratogenicity. Systemic absorption is minimal after ocular administration (0.03% of a dose). Cromolyn should only be given during pregnancy when the need has been clearly established.
Cromolyn ophthalmic Breastfeeding Warnings
There are no data on the excretion of cromolyn into human milk. Systemic absorption is insignificant after ocular administration (0.03% of a dose). The manufacturer recommends that caution be used when administering cromolyn ophthalmic to nursing women.
See Also...
- Cromolyn use while Breastfeeding (in more detail)
- cromolyn drops Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
